This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ betazole hydrochloride,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Urinary Retention: Bethanechol chloride is commonly prescribed to treat urinary retention, a condition characterized by the inability to empty the bladder fully. It works by stimulating the muscles of the bladder, causing it to contract and expel urine. This medication is particularly useful in cases of postoperative urinary retention or urinary retention due to neurogenic bladder dysfunction.

  2. Neurogenic Bladder: Neurogenic bladder is a dysfunction of the urinary bladder due to a neurological condition, such as spinal cord injury, multiple sclerosis, or Parkinson's disease. Bethanechol chloride may be used to improve bladder emptying in individuals with neurogenic bladder by increasing bladder muscle tone and promoting urination.

  3. Bladder Atony: Bladder atony refers to a condition in which the bladder muscles become weak and lose their ability to contract effectively, leading to urinary retention. Bethanechol chloride can help improve bladder muscle tone and restore bladder function in individuals with bladder atony.

  4. Urinary Incontinence: Although primarily used to treat urinary retention, bethanechol chloride may also have a role in managing certain types of urinary incontinence, particularly if the underlying cause is related to impaired bladder function. By enhancing bladder muscle contractions, it may help reduce episodes of urinary leakage.

  5. Gastrointestinal Disorders: In addition to its effects on the bladder, bethanechol chloride may also stimulate gastrointestinal motility and increase gastric emptying. It has been used off-label to treat certain gastrointestinal disorders characterized by delayed gastric emptying or gastrointestinal dysmotility, such as gastroparesis.

  6. Side Effects: Common side effects of bethanechol chloride include abdominal discomfort, cramps, diarrhea, nausea, and vomiting, which are primarily due to its gastrointestinal stimulatory effects. It may also cause headache, dizziness, sweating, and flushing. Rare but serious side effects include severe abdominal pain, urinary urgency, difficulty breathing, and irregular heartbeat.

  7. Contraindications: Bethanechol chloride is contraindicated in individuals with a history of asthma, peptic ulcer disease, intestinal obstruction, or bladder obstruction. It should be used with caution in patients with cardiovascular diseases, as it can cause bradycardia (slow heart rate) and hypotension (low blood pressure).

  8. Dosage and Administration: The dosage of bethanechol chloride varies depending on the individual's condition and response to treatment. It is usually taken orally, either with or without food, and the dose may be adjusted by a healthcare provider based on the patient's needs.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of betazole hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Bifidobacterium longum Reduces
species Parabacteroides distasonis Reduces
species Veillonella atypica Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by betazole hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Bilophila genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Veillonella genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Eggerthella genus Decreases
0 1 Bacteroides genus Decreases
0 1 Roseburia genus Decreases
0 1 Parabacteroides genus Decreases
1 0 Akkermansia genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Blautia genus Decreases
0 1 Agathobacter genus Decreases
0 1 Clostridium genus Decreases
0 1 Enterocloster genus Decreases
0 1 Clostridioides genus Decreases
0 1 Odoribacter genus Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Veillonella parvula species Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 Bacteroides caccae species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Eggerthella lenta species Decreases
0 1 Veillonella rodentium species Decreases
0 1 Veillonella dispar species Decreases
0 1 Veillonella sp. S12025-13 species Decreases
0 1 Veillonella nakazawae species Decreases
0 1 Veillonella rogosae species Decreases
0 1 Veillonella atypica species Decreases
0 1 Eggerthella guodeyinii species Decreases
1 0 Parabacteroides distasonis species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Blautia obeum species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Roseburia hominis species Decreases
1 0 Clostridium perfringens species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Odoribacter splanchnicus species Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases

Impact of betazole hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.3 0.3
Acne 0 0
ADHD 0.3 0.2 0.5
Age-Related Macular Degeneration and Glaucoma 0.1 0.1 0
Allergic Rhinitis (Hay Fever) 0.3 0.2 0.5
Allergies 0.8 0.3 1.67
Allergy to milk products 0.2 0.2 0
Alopecia (Hair Loss) 0.1 0.1
Alzheimer's disease 0.7 1.9 -1.71
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.2 0.1 1
Ankylosing spondylitis 0.6 0.1 5
Anorexia Nervosa 0.1 0.3 -2
Antiphospholipid syndrome (APS) 0.3 0.3 0
Asthma 0.9 0.6 0.5
Atherosclerosis 0.1 0.5 -4
Atrial fibrillation 0.5 0.5 0
Autism 1.3 1.2 0.08
Autoimmune Disease 0 0.1 0
Barrett esophagus cancer 0.3 0.3
benign prostatic hyperplasia 0.1 -0.1
Biofilm 0.3 0.3
Bipolar Disorder 0.6 0.5 0.2
Brain Trauma 0 0.2 0
Cancer (General) 0.3 0.5 -0.67
Carcinoma 0.7 0.2 2.5
Celiac Disease 0.7 0.9 -0.29
Cerebral Palsy 0.5 0.2 1.5
Chronic Fatigue Syndrome 0.9 1.2 -0.33
Chronic Kidney Disease 0.9 0.5 0.8
Chronic Lyme 0 0.2 0
Chronic Obstructive Pulmonary Disease (COPD) 0.3 0.3 0
Chronic Urticaria (Hives) 0.3 0.1 2
Coagulation / Micro clot triggering bacteria 0.1 0.1 0
Cognitive Function 0.2 0.1 1
Colorectal Cancer 0.4 0.3 0.33
Constipation 0.1 0.1 0
Coronary artery disease 0 0.5 0
COVID-19 1.8 2.1 -0.17
Crohn's Disease 1.2 0.5 1.4
Cushing's Syndrome (hypercortisolism) 0.1 -0.1
cystic fibrosis 0.3 -0.3
deep vein thrombosis 0 0.2 0
Denture Wearers Oral Shifts 0.5 0.5
Depression 2 1.4 0.43
Dermatomyositis 0 0
Eczema 0.3 0.1 2
Endometriosis 0.2 0.4 -1
Eosinophilic Esophagitis 0.3 -0.3
Epilepsy 0.3 0.4 -0.33
erectile dysfunction 0.1 0 0
Fibromyalgia 0.9 0.2 3.5
Functional constipation / chronic idiopathic constipation 0.6 0.7 -0.17
gallstone disease (gsd) 0.4 0.2 1
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.3 0.3 0
Generalized anxiety disorder 0.3 0.3 0
giant cell arteritis 0 0
Gout 0.6 0.1 5
Graves' disease 0.5 0.5 0
Gulf War Syndrome 0.1 0.2 -1
Halitosis 0.4 0.4
Hashimoto's thyroiditis 0.6 0.5 0.2
Heart Failure 0.2 0.2 0
hemorrhagic stroke 0.1 0.1
Hidradenitis Suppurativa 0.4 0.3 0.33
High Histamine/low DAO 0.1 0 0
hypercholesterolemia (High Cholesterol) 0 0.1 0
hyperglycemia 0.5 0.4 0.25
Hyperlipidemia (High Blood Fats) 0.4 0.4
hypersomnia 0.3 -0.3
hypertension (High Blood Pressure 0.4 0.7 -0.75
Hypothyroidism 0 0.2 0
Hypoxia 0.3 0.3
IgA nephropathy (IgAN) 0.3 0.9 -2
Inflammatory Bowel Disease 1.9 1.9 0
Insomnia 0.4 0.6 -0.5
Intelligence 0.3 0.3
Intracranial aneurysms 0.2 0.2
Irritable Bowel Syndrome 1.5 0.7 1.14
ischemic stroke 0.6 0.2 2
Liver Cirrhosis 1.7 1 0.7
Long COVID 1.6 0.8 1
Low bone mineral density 0.1 -0.1
Lung Cancer 0.6 0.1 5
Mast Cell Issues / mastitis 0 0
ME/CFS with IBS 0 0.2 0
ME/CFS without IBS 0.5 0.3 0.67
Menopause 0.3 0.1 2
Metabolic Syndrome 1.7 1.2 0.42
Mood Disorders 2.3 1 1.3
multiple chemical sensitivity [MCS] 0.3 0 0
Multiple Sclerosis 1.1 0.5 1.2
Multiple system atrophy (MSA) 0.2 0.1 1
myasthenia gravis 0.1 -0.1
neuropathic pain 0.2 0.4 -1
Neuropathy (all types) 0.2 0.2 0
neuropsychiatric disorders (PANDAS, PANS) 0 0
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.8 0.6 0.33
NonCeliac Gluten Sensitivity 0.4 0.1 3
Obesity 1.3 0.7 0.86
obsessive-compulsive disorder 0.5 0.3 0.67
Osteoarthritis 0.7 0.2 2.5
Osteoporosis 0.6 0.2 2
pancreatic cancer 0 0
Parkinson's Disease 1 1.9 -0.9
Polycystic ovary syndrome 0.5 0.6 -0.2
Postural orthostatic tachycardia syndrome 0 0 0
Premenstrual dysphoric disorder 0.1 0.1 0
primary biliary cholangitis 0.3 0 0
Primary sclerosing cholangitis 1.1 0.3 2.67
Psoriasis 0.4 0.5 -0.25
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.9 0.6 0.5
Rosacea 0 0.1 0
Schizophrenia 1.7 0.6 1.83
scoliosis 0.3 -0.3
Sjögren syndrome 1 0.3 2.33
Sleep Apnea 0.1 0.4 -3
Slow gastric motility / Gastroparesis 0.4 0 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.4 0.1 3
Stress / posttraumatic stress disorder 0.3 0.7 -1.33
Systemic Lupus Erythematosus 0.9 0.6 0.5
Tic Disorder 0 0 0
Tourette syndrome 0 0.1 0
Type 1 Diabetes 0.8 0.3 1.67
Type 2 Diabetes 1.2 0.8 0.5
Ulcerative colitis 1.1 0.8 0.38
Unhealthy Ageing 0.8 0.3 1.67
Vitiligo 0.2 0.2 0

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]